Belite Bio, Inc (BLTE) Misses Q2 EPS by 3c

Belite Bio, Inc (NASDAQ: BLTE) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• RBC Capital Starts Shawbrook Group plc (SHAW:LN) at Outperform
• JPMorgan Upgrades Wanhua Chemical Group (600309:CH) to Overweight